HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simona Ruggieri Selected Research

Cognitive Dysfunction

1/2019DP71 and SERCA2 alteration in human neurons of a Duchenne muscular dystrophy patient.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Simona Ruggieri Research Topics

Disease

20Neoplasms (Cancer)
03/2020 - 05/2013
6Multiple Myeloma
07/2018 - 08/2013
3Breast Neoplasms (Breast Cancer)
04/2018 - 10/2016
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
10/2019 - 01/2019
2Glioblastoma (Glioblastoma Multiforme)
10/2019 - 10/2014
2Stomach Neoplasms (Stomach Cancer)
08/2018 - 11/2017
2Adenocarcinoma
11/2017 - 10/2017
2Anemia
02/2014 - 10/2013
1Inflammation (Inflammations)
09/2019
1Fibrosarcoma
09/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2019
1Cognitive Dysfunction
01/2019
1Renal Cell Carcinoma (Grawitz Tumor)
01/2019
1Monoclonal Gammopathy of Undetermined Significance
07/2018
1Prostatic Neoplasms (Prostate Cancer)
10/2017
1Endometrial Neoplasms (Endometrial Cancer)
02/2017
1Macular Degeneration (Age-Related Maculopathy)
10/2016
1Triple Negative Breast Neoplasms
10/2016
1Glioma (Gliomas)
10/2014
1Astrocytoma (Pilocytic Astrocytoma)
10/2014
1Meningioma (Meningiomas)
10/2014
1Paraproteinemias (Monoclonal Gammopathy)
02/2014
1Kidney Diseases (Kidney Disease)
10/2013
1Necrosis
08/2013
1Plasmacytoma
08/2013
1Osteoarthritis
06/2013
1Osteoporosis
06/2013
1Bone Diseases (Bone Disease)
06/2013
1Melanoma (Melanoma, Malignant)
05/2013
1Uveitis
08/2012
1Lymphoma (Lymphomas)
03/2012

Drug/Important Bio-Agent (IBA)

6CytokinesIBA
01/2019 - 05/2013
5Tryptases (Tryptase)IBA
04/2018 - 08/2016
4ErythropoietinFDA Link
01/2019 - 10/2013
3Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
09/2019 - 05/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2019 - 06/2013
3Proteins (Proteins, Gene)FDA Link
01/2019 - 02/2014
2apo-dystrophin 1IBA
10/2019 - 01/2019
2Protein Isoforms (Isoforms)IBA
10/2019 - 01/2019
2DystrophinIBA
10/2019 - 01/2019
2Bortezomib (Velcade)FDA Link
02/2014 - 08/2013
1Biomarkers (Surrogate Marker)IBA
03/2020
1Complement C3 (C3 Complement)IBA
09/2019
1PTX3 proteinIBA
09/2019
1Angiogenesis InhibitorsIBA
03/2019
1Bevacizumab (Avastin)FDA Link
01/2019
1OligonucleotidesIBA
08/2018
1Monoclonal AntibodiesIBA
08/2018
1RNA (Ribonucleic Acid)IBA
08/2018
1Transcription Factors (Transcription Factor)IBA
04/2018
1Chymases (Chymase)IBA
11/2017
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
10/2017
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
10/2017
1NestinIBA
05/2017
1Peptide Hydrolases (Proteases)FDA Link
02/2017
1ProgesteroneFDA LinkGeneric
10/2016
1Estrogens (Estrogen)FDA Link
10/2016
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
10/2016
1ParaffinIBA
10/2014
1Formaldehyde (Formol)FDA Link
10/2014
1Caspase 3 (Caspase-3)IBA
10/2014
1Messenger RNA (mRNA)IBA
02/2014
1Lenalidomide (CC 5013)FDA Link
02/2014
1((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA
08/2013
1Culture MediaIBA
06/2013
1Cholecalciferol (Vitamin D3)FDA Link
06/2013
1MART-1 AntigenIBA
05/2013
1AntibodiesIBA
05/2013

Therapy/Procedure

8Therapeutics
07/2019 - 08/2012
2Lasers (Laser)
05/2017 - 03/2012
1Drug Therapy (Chemotherapy)
01/2019
1Nephrectomy
01/2019
1Neoadjuvant Therapy
01/2019